Walgreens Sells Itself to Private Equity Firm in $10 Billion Deal

Published On Mar 6, 2025, 7:05 PM

Walgreens Boots Alliance is being acquired by private equity firm Sycamore Partners for $10 billion, following a significant decline in its business performance and a 50% drop in stock value over the past year. The pharmacy chain has faced challenges due to falling prescription reimbursements, reduced retail sales, and increasing competition from larger retailers like Amazon and Walmart. Despite its struggles, Walgreens recently reported better-than-expected earnings, which may have influenced the timing of the acquisition. The deal represents a shift for Walgreens as it exits the public market amid ongoing operational pressures.

Stock Forecasts

WBA

Positive

The acquisition by Sycamore Partners indicates a desire to restructure and potentially rejuvenate Walgreens. Given the purchase price of $11.45 per share with an 8% premium suggests confidence from the private equity firm in addressing the underlying issues facing Walgreens and potential improvement post-acquisition.

Related News

Walgreens Boots Alliance on Thursday entered into an agreement with private equity firm Sycamore Partners to go private. The deal is valued at $10 billion.

Stocks pulled back on Friday as investors digested news that Trump tariffs on Canada, Mexico and China would begin on Saturday.

XLK
F
WBA
VRTX
SPY

Caution reigns ahead of December's jobs report, which will shape bets on the chances of Fed rate cuts.

WBA
DAL
XHB